Related Experiment Video
Updated: Oct 14, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose
Siri Shastry1, Ishak Nobel2, Lisa R Allen1
1Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Objectives:
Medications for opioid use disorder (MOUD) reduce opioid overdose (OD) deaths; however, prevalence and misuse of MOUD in ED patients presenting with opioid overdose are unclear, as are any impacts of existing MOUD prescriptions on subsequent OD severity.
Methods:
This was a prospective observational cohort of ED patients with opioid OD at two tertiary-care hospitals from 2015 to 19. Patients with confirmed opioid OD (via urine toxicology) were included, while patients with alternate diagnoses, insufficient data, age < 18, and prisoners were excluded. OD severity was defined using: (a) hospital LOS (days); and (b) in-hospital mortality. Time trends by calendar year and associations between MOUD and study outcomes were calculated.
Results:
In 2829 ED patients with acute drug OD, 696 with confirmed opioid OD were included. Overall, 120 patients (17%) were previously prescribed any MOUD, and MOUD prevalence was significantly higher in 2018 and 2019 compared to 2016 (20.1% and 27.8% vs. 8.8%, p < 0.05). Odds of MOUD misuse were significantly higher for methadone (OR 3.96 95% CI 2.57-6.12) and lowest for buprenorphine (OR 1.16, p = NS). Mean LOS was over 50% longer for methadone (3.08 days) compared to buprenorphine and naltrexone (both 2.0 days, p = NS). Following adjustment for confounders, buprenorphine use was associated with significantly shorter LOS (IRR -0.44 (95%CI -0.85, -0.04)). Odds of death were 30% lower for patients on any MOUD (OR 0.70, 95%CI 0.09-5.72), but highest in the methadone group (OR 0.82, 95%CI 0.10-6.74).
Conclusions:
While MOUD prevalence significantly increased over the study period, MOUD misuse occurred for patients taking methadone, and OD LOS overall was lower in patients with any prior buprenorphine prescription.
Insights
Medications for opioid use disorder (MOUD) prescriptions increased, but misuse was noted with methadone. Prior buprenorphine use was linked to shorter opioid overdose (OD) lengths of stay.
Area of Science:
- Emergency Medicine
- Addiction Medicine
- Pharmacology
Background:
- Medications for opioid use disorder (MOUD) are crucial for reducing opioid overdose (OD) mortality.
- The prevalence and misuse patterns of MOUD among emergency department (ED) patients presenting with OD are not well-understood.
- The impact of existing MOUD prescriptions on subsequent OD severity requires further investigation.
Purpose of the Study:
- To determine the prevalence and trends of MOUD use in ED patients with opioid overdose.
- To investigate the misuse of different MOUD formulations in this patient population.
- To assess the association between prior MOUD prescriptions and OD severity, including length of stay (LOS) and in-hospital mortality.
Main Methods:
- A prospective observational cohort study was conducted involving ED patients with confirmed opioid overdose at two tertiary-care hospitals between 2015 and 2019.
- Patients were included based on confirmed opioid OD via urine toxicology; exclusions included alternate diagnoses, insufficient data, age < 18, and prisoners.
- Opioid overdose severity was measured by hospital LOS and in-hospital mortality. Time trends and associations between MOUD and outcomes were analyzed.
Main Results:
- Of 696 patients with confirmed opioid OD, 17% had a prior MOUD prescription, with prevalence increasing significantly from 2016 to 2019.
- Methadone showed higher odds of misuse (OR 3.96) compared to buprenorphine (OR 1.16).
- Patients on buprenorphine had significantly shorter LOS (IRR -0.44) after adjustment. While any MOUD was associated with lower odds of death (OR 0.70), methadone had the highest odds (OR 0.82).
Conclusions:
- MOUD prevalence in ED patients with opioid overdose significantly increased during the study period.
- Misuse was observed, particularly with methadone, while buprenorphine was associated with reduced hospital LOS.
- These findings highlight the evolving landscape of MOUD use and its varied impact on OD outcomes in the ED setting.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Drug Abuse and Addiction: Pharmacological Phenomena
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Opioid Receptors: Overview